Provided by Tiger Trade Technology Pte. Ltd.

HUTCHMED

23.560
-0.320-1.34%
Volume:7.22M
Turnover:169.76M
Market Cap:20.54B
PE:5.78
High:24.160
Open:23.880
Low:23.040
Close:23.880
52wk High:30.750
52wk Low:18.360
Shares:872.00M
HK Float Shares:872.00M
Volume Ratio:1.18
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(LYR):4.076
ROE:45.25%
ROA:-1.62%
PB:2.12
PE(LYR):5.78
PS:4.78

Loading ...

HUTCHMED (China) Ltd - Ipsen Initiates Market Withdrawal and Recall of Tazverik in China

THOMSON REUTERS
·
Mar 09

HUTCHMED initiates TAZVERIK recall in China, Hong Kong and Macau

Reuters
·
Mar 09

HUTCHMED (China): Withdrawal Not Expected to Impact Financial Guidance

THOMSON REUTERS
·
Mar 09

HUTCHMED (China) Ltd - Withdraws Tazverik in Chinese Mainland, Hong Kong, Macau; Ends All Active Clinical Trials

THOMSON REUTERS
·
Mar 09

HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK® in China

GlobeNewswire
·
Mar 09

CLSA Trims HUTCHMED Target Price to HK$30.40, Keeps Outperform Rating

Stock News
·
Mar 09

BofA Securities Adjusts HUTCHMED Price Target to $21 From $22, Maintains Buy Rating

MT Newswires Live
·
Mar 06

HUTCHMED Announces Executive Reshuffle: Dr. Yansi Ya to Assume Senior and Lead Independent Director Role

Stock News
·
Mar 06

HUTCHMED (00013) Announces Retirement of Independent Non-Executive Director and Board Committee Changes

Bulletin Express
·
Mar 06

HUTCHMED China Ltd - Directorate Change

THOMSON REUTERS
·
Mar 06

Intended Retirement of Independent Non-Executive Director and Changes of Composition of Board Committees

THOMSON REUTERS
·
Mar 06

Intended Retirement of Independent Non-executive Director and changes of composition of board committees

GlobeNewswire
·
Mar 06

Daiwa Capital Markets Adjusts HUTCHMED Target Price to HK$26, Citing Consistent Annual Performance

Stock News
·
Mar 06

Biopharma Stocks Rally as Sector Gains Strategic "Emerging Pillar" Status

Stock News
·
Mar 06

Stock Track | HUTCHMED Soars 5.03% Intraday on Stellar Annual Results Showing 1111% Profit Surge

Stock Track
·
Mar 06

Hong Kong Market Announcement Highlights | JD Group Reports 13% Revenue Growth to 1.3091 Trillion Yuan for 2025

Stock News
·
Mar 06

Hutchmed's Profit Soars in 2025

MT Newswires Live
·
Mar 05

BRIEF-HUTCHMED (China) Logs FY Net Income Attributable $456.9 Mln

Reuters
·
Mar 05

HUTCHMED Reports 2025 Financial Results with $457 Million Net Profit Attributable to Shareholders

Stock News
·
Mar 05

HUTCHMED (00013) Announces 2025 Annual Results and Updates, Net Income at US$456.90 million

Bulletin Express
·
Mar 05